ONLINE DATABASE SEARCH HIV-LS-340-MEMO
1. 48365 HIV-LS-340; PUBMED-HIV-1/23/2006
Inhibitors of HIV-1 Protease by Using In Situ Click Chemistry
Whiting, M, Muldoon, J, Lin, YC, Silverman, SM, Lindstrom, W, Olson, AJ, Kolb, HC, Finn, MG, Sharpless, KB, Elder, JH, and Fokin, VV
Angew Chem Int Ed Engl 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16425339&dopt=abstract
2. 48366 HIV-LS-340; PUBMED-HIV-1/23/2006
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
Gallant, JE, DeJesus, E, Arribas, JR, Pozniak, AL, Gazzard, B, Campo, RE, Lu, B, McColl, D, Chuck, S, Enejosa, J, Toole, JJ, and Cheng, AK
N Engl J Med 2006. 354(3): 251-60
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16421366&dopt=abstract
3. 48367 HIV-LS-340; PUBMED-HIV-1/23/2006
Structure-Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor
Romines, KR, Freeman, GA, Schaller, LT, Cowan, JR, Gonzales, SS, Tidwell, JH, Andrews, CW 3rd, Stammers, DK, Hazen, RJ, Ferris, RG, Short, SA, Chan, JH, and Boone, LR
J Med Chem 2006. 49(2): 727-39
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16420058&dopt=abstract
4. 48368 HIV-LS-340; PUBMED-HIV-1/23/2006
HIV Integrase Inhibitors with Nucleobase Scaffolds: Discovery of a Highly Potent Anti-HIV Agent
Nair, V, Chi, G, Ptak, R, and Neamati, N
J Med Chem 2006. 49(2): 445-447
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16420027&dopt=abstract
5. 48369 HIV-LS-340; PUBMED-HIV-1/23/2006
Preferential Inhibition of the Magnesium-Dependent Strand Transfer Reaction of HIV-1 Integrase by {alpha}-Hydroxytropolones
Semenova, EA, Johnson, AA, Marchand, C, Davis, DA, Yarchoan, R, and Pommier, Y
Mol Pharmacol 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16418335&dopt=abstract
6. 48370 HIV-LS-340; EMBASE-HIV-1/24/2006
Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor
Sevigny, G, Stranix, B, Tian, B, Dubois, A, Sauve, G, Petropoulos, C, Lie, Y, Hellmann, N, Conway, B, and Yelle, J
Antiviral Research 2006. In Press, Uncorrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T2H-4J32H1X-2/2/84a20ee29617b8c623aa20df7790046f
7. 48371 HIV-LS-340; PUBMED-HIV-1/23/2006
Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat
Yajima, S, Shionoya, H, Akagi, T, and Hamasaki, K
Bioorg Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16413787&dopt=abstract
8. 48372 HIV-LS-340; PUBMED-HIV-1/23/2006
Design, synthesis, and anti-integrase activity of catechol-DKA hybrids
Maurin, C, Bailly, F, Mbemba, G, Mouscadet, JF, and Cotelle, P
Bioorg Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16412645&dopt=abstract
9. 48373 HIV-LS-340; PUBMED-HIV-1/23/2006
Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides
Brzozowski, Z, Saczewski, F, and Neamati, N
Bioorg Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16406643&dopt=abstract
10. 48374 HIV-LS-340; PUBMED-HIV-1/23/2006
Anti-HIV-1 protease- and HIV-1 integrase activities of Thai medicinal plants known as Hua-Khao-Yen
Tewtrakul, S, Itharat, A, and Rattanasuwan, P
J Ethnopharmacol 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16406414&dopt=abstract
11. 48375 HIV-LS-340; PUBMED-HIV-1/23/2006
Anti-Tat and anti-HIV activities of trimers of n-alkylglycines
Marquez, N, Sancho, R, Macho, A, Moure, A, Masip, I, Messeguer, A, and Munoz, E
Biochem Pharmacol 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16405868&dopt=abstract
12. 48376 HIV-LS-340; PUBMED-HIV-1/23/2006
Structural Insights into the Mechanisms of Drug Resistance in HIV-1 Protease NL4-3
Heaslet, H, Kutilek, V, Morris, GM, Lin, YC, Elder, JH, Torbett, BE, and Stout, CD
J Mol Biol 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16403521&dopt=abstract
13. 48377 HIV-LS-340; EMBASE-HIV-1/24/2006
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chains
Smith III, Amos B, Charnley, Adam K, Harada, Hironori, Beiger, Jason J, Cantin, Louis-David, Kenesky, Craig S, Hirschmann, Ralph, Munshi, Sanjeev, Olsen, David B, and Stahlhut, Mark W
Bioorganic & Medicinal Chemistry Letters 2006. 16(4): 859-863
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4HKMPP6-5/2/fde2a4c769b5d49d0744245042179c3a
14. 48378 HIV-LS-340; PUBMED-HIV-1/23/2006
Aminopyrimidinimino isatin analogues: design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties
Sriram, D, Bal, TR, and Yogeeswari, P
J Pharm Pharm Sci 2005. 8(3): 565-77
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16401403&dopt=abstract
15. 48379 HIV-LS-340; PUBMED-HIV-1/23/2006
Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices
Dong, J and Xiong, H
J Neurosci Res 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16400660&dopt=abstract
16. 48380 HIV-LS-340; EMBASE-HIV-1/24/2006
Norepinephrine inhibits human immunodeficiency virus type-1 infection through the NF-[kappa]B inactivation
Moriuchi, Masako, Yoshimine, Hiroyuki, Oishi, Kazunori, and Moriuchi, Hiroyuki
Virology 2006. 345(1): 167-173
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4HGM73D-3/2/9e133a28b35343316263be16e4bb9875
17. 48381 HIV-LS-340; EMBASE-HIV-1/24/2006
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Ruiz-Caro, Juliana, Basavapathruni, Aravind, Kim, Joseph T, Bailey, Christopher M, Wang, Ligong, Anderson, Karen S, Hamilton, Andrew D, and Jorgensen, William L
Bioorganic & Medicinal Chemistry Letters 2006. 16(3): 668-671
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4HKCYSV-1/2/ce87db516a8490685f5de13f308064a7
18. 48382 HIV-LS-340; PUBMED-HIV-1/23/2006
In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients
Gianotti, N, Galli, L, Boeri, E, Maillard, M, Serra, G, Ratti, D, Gallotta, G, Vacchini, D, Tremolada, Y, Lazzarin, A, Clementi, M, and Castagna, A
New Microbiol 2005. 28(4): 319-26
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16386016&dopt=abstract
19. 48383 HIV-LS-340; PUBMED-HIV-1/23/2006
R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors
Gondois-Rey, F, Biancotto, A, Fernandez, MA, Bettendroffer, L, Blazkova, J, Trejbalova, K, Pion, M, and Hirsch, I
J Virol 2006. 80(2): 854-65
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16378987&dopt=abstract
20. 48384 HIV-LS-340; PUBMED-HIV-1/23/2006
Discovery of Next Generation Inhibitors of HIV Protease
Spaltenstein, A, Kazmierski, WM, Miller, JF, and Samano, V
Curr Top Med Chem 2005. 5(16): 1589-607
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16375744&dopt=abstract
21. 48385 HIV-LS-340; EMBASE-HIV-1/24/2006
Conformationally restrained carbazolone-containing [alpha],[gamma]-diketo acids as inhibitors of HIV integrase
Li, Xingnan and Vince, Robert
Bioorganic & Medicinal Chemistry 2006. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4HYMW0Y-1/2/6bb52e518d534eb3fdb08a5f8ca2b7b6
22. 48386 HIV-LS-340; EMBASE-HIV-1/24/2006
Bleomycin has antiviral properties against drug-resistant HIV strains and sensitises virus to currently used antiviral agents
Georgiou, Niki A, van der Bruggen, Tjomme, Healy, Derek MC, van Tienen, Carla, de Bie, Prim, Oudshoorn, Maroeska, Marx, Joannes JM, and van Asbeck, BSweder
International Journal of Antimicrobial Agents 2006. 27(1): 63-68
HYPERLINK:
http://www.sciencedirect.com/science/article/B6T7H-4HR75KH-1/2/189ef187d2c7118ab04b119ddcba35aa
23. 48387 HIV-LS-340; EMBASE-HIV-1/24/2006
Modeling of activity of cyclic urea HIV-1 protease inhibitors using regularized-artificial neural networks
Fernandez, Michael and Caballero, Julio
Bioorganic & Medicinal Chemistry 2006. 14(1): 280-294
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF8-4H7T0J0-3/2/4614f155a6b59734916ea15c034c0d34
24. 48388 HIV-LS-340; WOS-HIV-1/15/2006
Synthetic approaches to nuclease-resistant, nonnatural dinucleotides of anti-HIV integrase interest
Chi, GC and Nair, V
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2005. 24(10-12): 1449-1468, 20
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234060900005
25. 48389 HIV-LS-340; WOS-HIV-1/15/2006
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8
Haskell, CA, Horuk, R, Liang, M, Rosser, M, Dunning, L, Islam, I, Kremer, L, Gutierrez, J, Marquez, G, Martinez, C, Biscone, MJ, Doms, RW, and Ribeiro, S
MOLECULAR PHARMACOLOGY 2006. 69(1): 309-316, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234252000032
26. 48390 HIV-LS-340; WOS-HIV-1/15/2006
Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1
Morris, KV and Looney, DJ
HUMAN GENE THERAPY 2005. 16(12): 1463-1472, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234253000011
27. 48391 HIV-LS-340; WOS-HIV-1/15/2006
Human immunodeficiency virus (HIV) entry inhibitors (CCR5 specific blockers) in development: Are they the next novel therapies?
Idemyor, V
HIV CLINICAL TRIALS 2005. 6(5): 272-277, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234165600005
28. 48392 HIV-LS-340; WOS-HIV-1/15/2006
Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal
Zhang, JZ, Liu, Y, Henao, J, Rugeles, MT, Li, JL, Chen, T, and He, JJ
GENE 2005. 363: 67-76, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234166700008
29. 48393 HIV-LS-340; WOS-HIV-1/15/2006
Second-generation cycloSal-d4TMP pronucleotides bearing esterase-cleavable sites - the "trapping" concept
Meier, C, Ducho, C, Jessen, H, Vukadinovic-Tenter, D, and Balzarini, J
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY 2005.(1): 197-206, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234237500019
30. 48394 HIV-LS-340; WOS-HIV-1/22/2006
Phenolics with anti-HSV and anti-HIV activities from Artocarpus gomezianus , Mallotus pallidus , and Triphasia trifolia
Likhitwitayawuid, K, Supudompol, B, Sritularak, B, Lipipun, V, Rapp, K, and Schinazi, RF
PHARMACEUTICAL BIOLOGY 2005. 43(8): 651-657, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234398600002
31. 48395 HIV-LS-340; WOS-HIV-1/22/2006
Simple synthesis and anti-HIV activity of novel cyclopentene phosphonate nucleosides
Kim, A and Hong, JH
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 1-8, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200001
32. 48396 HIV-LS-340; WOS-HIV-1/22/2006
New AZT conjugates as potent anti-HIV agents
You, ZQ and Lee, HJ
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 37-54, 18
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200005
33. 48397 HIV-LS-340; WOS-HIV-1/22/2006
Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine
Feng, JY, Myrick, FT, Margot, NA, Mulamba, GB, Rimsky, L, Borroto-Esoda, K, Selmi, B, and Canard, B
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 89-107, 19
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200009
34. 48398 HIV-LS-340; WOS-HIV-1/22/2006
Synthesis and antiviral evaluation of novel 4 '-hydroxymethyl branched apiosyl nucleosides
Kim, JW and Hong, JH
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2006. 25(1): 109-117, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234388200010
35. 48399 HIV-LS-340; WOS-HIV-1/22/2006
CCR5 Delta 32, CCR2-64I, and SDF1-3 ' A polymorphisms related to resistance to HIV-1 infection and disease in the Ecuadorian population
Paz-y-Mino, C, Morillo, SA, Celi, AP, Witte, T, Guijarro, MJM, Collantes, JC, and Leone, PE
HUMAN BIOLOGY 2005. 77(4): 521-526, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234289000010
36. 48400 HIV-LS-340; WOS-HIV-1/22/2006
Tipranavir: a protease inhibitor for multi-drug resistant HIV-1
Best, B and Haubrich, R
EXPERT OPINION ON INVESTIGATIONAL DRUGS 2006. 15(1): 59-70, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000234421000006